| NCT Number | NCT07466862 |
| Lead Sponsor | Gali Perel |
| Conditions | Cancer, Sarcopenia, Muscle Mass Loss |
| Enrollment | 200 participants |
| Start Date | 2026-04 |
| Primary Completion | 2028-06 (estimated) |
| Study Completion | 2028-06 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-02 |